Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Metabolism and cancer in La Jolla.

Shaw RJ, Evans RM, Simon MC.

Cancer Res. 2010 May 15;70(10):3864-9. doi: 10.1158/0008-5472.CAN-09-4529. Epub 2010 May 4. No abstract available.

2.

Metabolic profiling of cell growth and death in cancer: applications in drug discovery.

Boros LG, Cascante M, Lee WN.

Drug Discov Today. 2002 Mar 15;7(6):364-72. Review.

PMID:
11893545
3.

SnapShot: cancer metabolism pathways.

Finley LW, Zhang J, Ye J, Ward PS, Thompson CB.

Cell Metab. 2013 Mar 5;17(3):466-466.e2. doi: 10.1016/j.cmet.2013.02.016. No abstract available.

4.

Abetimus: Abetimus sodium, LJP 394.

[No authors listed]

BioDrugs. 2003;17(3):212-5.

PMID:
12749759
5.

Advances in metabolism.

Tsoukas MA, Farr OM, Mantzoros CS.

Metabolism. 2013 Dec;62(12):1700-13. doi: 10.1016/j.metabol.2013.09.003. Epub 2013 Oct 7. Review. No abstract available.

PMID:
24112391
6.

[Current status and prospect of metabonomics].

Xu M, Lin DH, Liu CX.

Yao Xue Xue Bao. 2005 Sep;40(9):769-74. Review. Chinese. No abstract available.

PMID:
16342674
7.

Autophagy: from structure to metabolism to therapeutic regulation.

Jardon MA, Rothe K, Bortnik S, Vezenkov L, Jiang X, Young RN, Lum JJ, Gorski SM.

Autophagy. 2013 Dec;9(12):2180-2. doi: 10.4161/auto.26378. Epub 2013 Sep 30.

PMID:
24201076
8.

Cancer. Systems biology, metabolomics, and cancer metabolism.

Tomita M, Kami K.

Science. 2012 May 25;336(6084):990-1. doi: 10.1126/science.1223066. No abstract available.

PMID:
22628644
9.

The disulfide compound α-lipoic acid and its derivatives: A novel class of anticancer agents targeting mitochondria.

Dörsam B, Fahrer J.

Cancer Lett. 2016 Feb 1;371(1):12-9. doi: 10.1016/j.canlet.2015.11.019. Epub 2015 Nov 18. Review.

PMID:
26604131
10.

Mevalonate metabolism in cancer.

Gruenbacher G, Thurnher M.

Cancer Lett. 2015 Jan 28;356(2 Pt A):192-6. doi: 10.1016/j.canlet.2014.01.013. Epub 2014 Jan 24. Review.

PMID:
24467965
11.

The La autoantigen is a malignancy-associated cell death target that is induced by DNA-damaging drugs.

Al-Ejeh F, Darby JM, Brown MP.

Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5509s-5518s.

12.

Metabolism in cancer metastasis.

Weber GF.

Int J Cancer. 2016 May 1;138(9):2061-6. doi: 10.1002/ijc.29839. Epub 2015 Sep 22. Review.

13.

Cancer cell metabolism.

Cairns RA, Harris I, McCracken S, Mak TW.

Cold Spring Harb Symp Quant Biol. 2011;76:299-311. doi: 10.1101/sqb.2011.76.012856. Epub 2011 Dec 12. Review.

PMID:
22156302
14.

Metabolism and cancer mix in Madrid.

Shaw RJ.

EMBO Rep. 2010 Apr;11(4):249-51. doi: 10.1038/embor.2010.40. Epub 2010 Mar 19.

15.

Modeling cancer metabolism on a genome scale.

Yizhak K, Chaneton B, Gottlieb E, Ruppin E.

Mol Syst Biol. 2015 Jun 30;11(6):817. doi: 10.15252/msb.20145307. Review.

16.

A return to cancer metabolism.

Semenza GL.

J Mol Med (Berl). 2011 Mar;89(3):203-4. doi: 10.1007/s00109-011-0733-7. Epub 2011 Feb 8. No abstract available.

PMID:
21301793
17.

Mutations, tissue type both influence cancer metabolism.

[No authors listed]

Cancer Discov. 2012 Mar;2(3):OF1. doi: 10.1158/2159-8290.CD-NB2012-014. Epub 2012 Feb 16.

18.

Cancer cell metabolism: its relevance to cancer treatment.

Lupulescu A.

Cancer Invest. 1999;17(6):423-33. Review. No abstract available.

PMID:
10434953
19.

Reprogrammed metabolism of cancer cells as a potential therapeutic target.

Keijer J, van Dartel DA.

Curr Pharm Des. 2014;20(15):2580-94. Review.

PMID:
23859616
20.

Emerging concepts: linking hypoxic signaling and cancer metabolism.

Lyssiotis CA, Vander-Heiden MG, Muñoz-Pinedo C, Emerling BM.

Cell Death Dis. 2012 May 3;3:e303. doi: 10.1038/cddis.2012.41. No abstract available. Erratum in: Cell Death Dis. 2012;3:e329. Heiden, M G V [corrected to Vander-Heiden, M G].

Supplemental Content

Support Center